EAGLE PHARMACEUTICALS, INC. (EGRX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	55.3	97.7	103.2	109.8	78.8	114.7	52.8	79.1
Short-term investments		5.3
Accounts receivable, net	72.4	41.1	51.1	48.0	66.5	53.8	42.2	26.3
Inventories	47.8	21.9	8.1	6.6	8.3	5.1	2.7	15.0
Other current assets	13.2	6.6	3.7	15.1	10.3	15.1	11.4	1.9
Total current assets	188.8	172.6	166.1	179.4	163.8	188.7	109.1	122.3
Property, plant, and equipment, net	1.2	1.6	2.1	2.2	2.4	6.8	3.3	2.2
Intangibles	118.3	10.7	12.9	15.6	18.1	23.3	33.4
Goodwill	45.0	39.7	39.7	39.7	39.7	39.7	39.7
Other fixed assets	25.7	10.3	17.2	3.9	0.7	0.1	0.1	0.1
Total assets	406.2	253.7	253.2	254.6	238.6	270.1	214.3	124.6

Accounts payable	19.0	16.4	6.3	5.5	9.9	12.0	14.7	3.9
Accrued expenses	85.8	32.3	23.8	28.4	23.5	21.1	25.2	24.4
Current portion of long-term debt	6.3	25.6	8.0	5.0	6.3	4.9	0.0	0.0
Current portion of long-term debt	6.3	25.6	8.0	5.0	6.3	4.9
Deferred revenues								6.0
Other current liabilities						9.3	1.0
Total current liabilities	111.1	74.4	38.1	38.8	39.7	47.3	41.0	34.3
Long-term debt	56.2		25.1	33.6	38.2	42.9
Other liabilities	5.3	2.9	4.0	3.0
Total liabilities	172.6	77.3	67.2	75.4	77.8	90.2	41.0	34.3

Shareholders' equity [+]	233.6	176.5	186.0	179.2	160.8	179.9	173.4	90.3
Paid-in capital	366.3	325.8	305.4	278.5	256.5	233.6	213.9	197.4
Retained earnings	111.5	75.9	84.5	72.5	58.2	26.3	-25.7	-107.1
Treasury stock		-225.1	-203.9	-171.9	-153.9	-80.8	-37.0
Tangible shareholders' equity	70.2	126.0	133.4	123.8	102.9	116.8	100.2	90.3